Literature DB >> 1985543

Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure.

H Tanaka1, H Sugimoto, T Yoshioka, T Sugimoto.   

Abstract

To better understand the role of granulocyte elastase (GE) in mediating tissue injury during sepsis, GE levels were measured in plasma and bronchoalveolar lavage fluid (BALF) in patients with septic shock (n = 16) and hemorrhagic shock (n = 30). Granulocyte elastase levels were compared to levels of alpha 1-protease inhibitor (alpha 1-PI). Results show that although plasma GE-alpha 1-PI complex was initially elevated in patients with hemorrhagic and septic shock, elevations in plasma GE-alpha 1-PI complex (831 +/- 241 micrograms/L) persisted in septic shock patients. alpha 1-Protease inhibitor levels in serum were increased, resulting in an inhibition of serum GE activity. Granulocyte elastase activity in BALF, however, was significantly higher in those patients with septic, as compared to hemorrhagic shock (31.4 +/- 25.8 versus 3.7 +/- 4.0 U/L, respectively). In addition GE levels were compared to other parameters, including respiratory index, blood neutrophil count, and plasma levels of endotoxin, fibronectin, and coagulation factor XIII. Significant correlations were observed between GE-alpha 1-PI and increased endotoxin concentration and decreased fibronectin and coagulation factor XIII levels. Significant correlation was found also between GE activity in BALF and respiratory index. These findings suggest that severe tissue damage occurred in patients with septic shock complicated by multiple-organ failure. Although GE activity appeared to be adequately inhibited by alpha 1-PI in blood, increased GE activity in local tissues, such as lung alveoli, may be responsible for significant local tissue injury during septic shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985543      PMCID: PMC1358315          DOI: 10.1097/00000658-199101000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Multiple-organ-failure syndrome.

Authors:  C J Carrico; J L Meakins; J C Marshall; D Fry; R V Maier
Journal:  Arch Surg       Date:  1986-02

Review 2.  Leukocytic proteases and the immunologic release of lysosomal enzymes.

Authors:  G Weissmann; R B Zurier; S Hoffstein
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

3.  [Isolation and characterization of the fibrin stabilizing factor from human thrombocytes].

Authors:  H Bohn
Journal:  Thromb Diath Haemorrh       Date:  1970-06-30

4.  The induction of emphysema with elastase. I. The evolution of the lesion and the influence of serum.

Authors:  P D Kaplan; C Kuhn; J A Pierce
Journal:  J Lab Clin Med       Date:  1973-09

5.  The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1974-03-01

6.  Alpha-2-plasmin-inhibitor inactivation by human granulocyte elastase.

Authors:  M Gramse; K Havemann; R Egbring
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

7.  Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers.

Authors:  S F Smith; A Guz; N T Cooke; G H Burton; T D Tetley
Journal:  Clin Sci (Lond)       Date:  1985-07       Impact factor: 6.124

8.  Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery.

Authors:  K H Duswald; M Jochum; W Schramm; H Fritz
Journal:  Surgery       Date:  1985-11       Impact factor: 3.982

9.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Clotting and other plasma factors in experimental endotoxemia: inhibition of degradation by exogenous proteinase inhibitors.

Authors:  M Jochum; J Witte; H Schiessler; H K Selbmann; G Ruckdeschl; H Fritz
Journal:  Eur Surg Res       Date:  1981       Impact factor: 1.745

View more
  16 in total

1.  Recombinant factor XIII mitigates hemorrhagic shock-induced organ dysfunction.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Inga V Malinina; Edwin A Deitch; Eva H Olsen
Journal:  J Surg Res       Date:  2010-12-31       Impact factor: 2.192

2.  The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer.

Authors:  Junichi Nishiyama; Mitsumasa Matsuda; Satoko Ando; Miyoko Hirasawa; Toshiyasu Suzuki; Hiroyasu Makuuchi
Journal:  Surg Today       Date:  2011-12-27       Impact factor: 2.549

Review 3.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 4.  Genetic determinants of mortality in acute necrotizing pancreatitis.

Authors:  H Rinderknecht
Journal:  Int J Pancreatol       Date:  1994-08

5.  Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release.

Authors:  U Bank; D Reinhold; D Kunz; H U Schulz; C Schneemilch; W Brandt; S Ansorge
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

6.  Acceleration of superoxide production from leukocytes in trauma patients.

Authors:  H Tanaka; H Ogura; J Yokota; H Sugimoto; T Yoshioka; T Sugimoto
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

7.  Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide.

Authors:  H Sato; K Fujiwara; J Sagara; S Bannai
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

8.  Identification and biochemical characterization of human plasma neutrophil inhibitor in vitro.

Authors:  Y Abe; Y Kashu; T Lee; M Sato; K Kimura; S Kimura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 9.  Metabolic basis for management of the septic surgical patient.

Authors:  J H Shaw; J B Koea
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

Review 10.  Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target.

Authors:  Young Ha Ahn; Se-Chan Oh; Shengtao Zhou; Tae-Don Kim
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.